5 Key Takeaways

• 1

  The FDA has granted Orphan Drug designation to FL118 for treating pancreatic cancer.

• 2

  FL118 is a novel drug candidate developed by Canget BioTekpharma.

• 3

  The drug candidate binds to the DDX5 protein and has shown antitumor activity in preclinical studies.

• 4

  FL118 is derived from camptothecin, an organic compound from a tree native to China.

• 5

  Research leading to FL118's discovery was conducted by Dr. Fengzhi Li at Roswell Park Comprehensive Cancer Center.